Medical devices in-depth product overview: Pain control with electrical stimulation - Verdict Medical Devices
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Medical devices in-depth product overview: Pain control with electrical stimulation

17 May 2021 (Last Updated September 9th, 2021 14:08)

Sponsored by Sandvik Sponsored by Visit Company
Medical devices in-depth product overview: Pain control with electrical stimulation

Pain control with electrical stimulation is life-changing for patients with long-term conditions that continuously or periodically cause them pain. The primary shortfall of using drugs to manage pain are negative health side effects, such as liver problems, which are further exacerbated as many patients need to increase their dosage over time

Globally, chronic conditions that require pain control are on the rise, especially in regions with an ageing population. According to a report by Grand View Research, the global pain management devices market is expected to grow at a compound annual growth rate of 9.0% from 2020 to 2027. With this in mind, the pressure for manufacturers to design and develop pain control devices is growing.

Neurostimulation systems are a tried and tested method of managing pain using a medical device. Spinal cord stimulation (SCS) devices can be controlled by the patient and work by transmitting electrical impulses to disrupt pain signals travelling between the spinal cord and the brain. These systems are comprised of the neurostimulator itself, a handheld device, and thin, insulated medical wires that deliver electrical pulses.

These insulated wires must be optimised to ensure they work efficiently, so many OEMs turn to specialists such as Sandvik with its EXERA® range of medical wire to develop components that are calibrated for the task. From its extensive range of stainless steels, precious metals and CoCr alloys, as well as coatings and surface treatments, Sandvik utilises its expertise to help customers from the design stage on into production.

For SCS applications, many manufacturers have used the EXERA® platinum iridium alloys (EXERA® Pt10Ir and EXERA® Pt20Ir), which offer excellent biocompatibility, along with radiopacity, moderate strength and good formability. To maximise fatigue strength for implantable devices, these platinum-iridium alloys are delivered with the highest surface finish (Medical class).

For the insulated coating, Sandvik offers PTFE synthetic fluoropolymer coating, along with other coatings that are in use in the medical market, for temporary and permanent implant. Coating thickness ranging from 0.00127mm to 0.0127mm that meet NEMA and JIS standards.

For more information about EXERA® fine medical wire-components, including available materials and surface treatments, download the white paper below.


Free Whitepaper

Medical Metals and Coatings

Medical-wire components are essential for therapeutic devices. They play the important role of transmitting, sensing or stimulating signals within the body, all the while needing to be biocompatible and offer various features (depending on the application) such as lubricity, conductivity or fatigue resistance. OEMs must choose an appropriate metal material and configuration (such as thickness or coiling), as well as a suitable coating to ensure that the medical device is as efficient and reliable as it can be.

This whitepaper outlines the support you can receive from Sandvik experts for materials and coating selection, with an included example of how materials are selected for orthopedic applications, which marked the company’s entrance into the medical field.

By clicking the “Submit” button above, you accept the Terms & Conditions and acknowledge that your data will be used as described in the Sandvik Privacy Policy.

We will also collect and use the information you provide for carefully considered and specific purposes, where we believe we have a legitimate interest in doing so, for example to send you communications about similar products and services we offer. We will always give you an option to opt out of any future communications from us. You can find out more about our legitimate interest activity in our privacy policy here. ‘We’ includes Verdict Media Limited and other GlobalData brands as detailed here.